semaglutide and fda The approved a pill version of the GLP-1 receptor agonist (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday. The once-daily 25 U.S. FDA finds no evidence

Protein a health trend beyond GLP-1 users had some of the biggest gains, with protein supplements and meal replacements increasing 12.4% in 2025, according to Spins data

Legumes : Beans and lentils provide the necessary amino acids for production

What B12 Injections Can Help With Common reasons clients across metro Atlanta book this treatment

Experimentally, the type 2 diabetes (T2D) group underwent HFD feeding for 4 weeks followed by intraperitoneal STZ injections (50 mg/kg for 5 consecutive days) according to the protocol described in previous studies (Malla et al., 2015)

Does not seem to have a major effect on immune functioning